8-K: OneMedNet Corporation Faces Nasdaq Delisting Threat Due to Low Stock Price

OneMedNet Corporation received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement, potentially leading to delisting.

Summary

• OneMedNet Corporation received a notice from Nasdaq on April 10, 2025, stating that it does not meet the minimum bid price of $1.00 per share for continued listing.
• The company has until October 7, 2025, to regain compliance by maintaining a stock price of $1.00 or higher for at least ten consecutive business days.
• If compliance is not achieved by the initial deadline, OneMedNet may be eligible for an additional 180-day compliance period if it meets other listing requirements and provides notice of its intent to cure the deficiency, potentially through a reverse stock split.
• There is no guarantee that OneMedNet will regain compliance, and failure to do so could result in the delisting of its securities from Nasdaq.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice, indicating financial distress and potential loss of investor confidence. While the company is taking steps to address the issue, the outcome is uncertain.

Positives

• OneMedNet has the opportunity to regain compliance with Nasdaq's minimum bid price rule by October 7, 2025.
• The company may be eligible for an additional 180-day compliance period if it meets certain requirements.
• OneMedNet is considering options, including a reverse stock split, to address the deficiency.

Negatives

• OneMedNet is currently not in compliance with Nasdaq's minimum bid price requirement.
• Failure to regain compliance could result in the delisting of the company's securities from Nasdaq.
• The notice from Nasdaq could negatively impact investor confidence.

Risks

• The company's stock price may not increase sufficiently to meet the $1.00 minimum bid price requirement within the given timeframe.
• A reverse stock split may not be effective in maintaining compliance and could have negative consequences for shareholders.
• Delisting from Nasdaq could reduce the liquidity and market value of OneMedNet's stock.

Future Outlook

The company intends to actively monitor its stock price and consider available options, including a reverse stock split, to regain compliance with the Nasdaq listing rules; however, there is no assurance that it will be successful.

Management Comments

• Aaron Green, Chief Executive Officer, signed the report on behalf of OneMedNet Corporation.

Industry Context

Many small-cap companies struggle to maintain the minimum bid price required for listing on major exchanges like Nasdaq, especially in volatile market conditions. Delisting can significantly impact a company's access to capital and investor base.

Comparison to Industry Standards

• Companies like Digital Ally and CBAK Energy Technology have faced similar delisting warnings from Nasdaq due to low stock prices.
• Reverse stock splits are a common strategy employed by companies in this situation, but their effectiveness varies depending on the underlying business fundamentals and market sentiment.
• The success of regaining compliance often depends on the company's ability to improve its financial performance and attract investor interest.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment if the company is delisted.
• Employees may face uncertainty regarding their job security.
• The company's ability to raise capital and fund its operations could be negatively impacted.

Next Steps

• OneMedNet will monitor its stock price.
• OneMedNet will consider implementing available options to regain compliance with the Bid Price Rule, including a reverse stock split.

Key Dates

Keywords

delisting, Nasdaq, minimum bid price, compliance, OneMedNet, ONMD, reverse stock split